Jerome D. Jabbour
2017
In 2017, Jerome D. Jabbour earned a total compensation of $1.3M as Chief Executive Officer and President at Matinas BioPharma Holdings, a 164% increase compared to previous year.
Compensation breakdown
| Bonus | $90,000 |
|---|---|
| Option Awards | $881,483 |
| Salary | $299,000 |
| Total | $1,270,483 |
Jabbour received $881.5K in option awards, accounting for 69% of the total pay in 2017.
Jabbour also received $90K in bonus and $299K in salary.
Rankings
In 2017, Jerome D. Jabbour's compensation ranked 7,825th out of 14,666 executives tracked by ExecPay. In other words, Jabbour earned more than 46.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,825 out of 14,666 | 47th |
Division Manufacturing | 2,935 out of 5,768 | 49th |
Major group Chemicals And Allied Products | 953 out of 2,074 | 54th |
Industry group Drugs | 740 out of 1,730 | 57th |
Industry Pharmaceutical Preparations | 579 out of 1,329 | 56th |
Source: SEC filing on September 24, 2018.
Jabbour's colleagues
We found four more compensation records of executives who worked with Jerome D. Jabbour at Matinas BioPharma Holdings in 2017.
2017
Roelof Rongen
Matinas BioPharma Holdings
Chief Executive Officer
2017
Dominick DiPaolo
Matinas BioPharma Holdings
Former Senior Vice President, Quality and Regulatory Compliance
2017
Raphael Mannino
Matinas BioPharma Holdings
Chief Scientific Officer
2017
Gary Gaglione
Matinas BioPharma Holdings
Chief Financial Officer
News
Matinas BioPharma Holdings CEO Jerome Jabbour's 2022 pay falls 55% to $1.7M
September 19, 2023
Matinas BioPharma Holdings CEO Jerome Jabbour's 2021 pay jumps 26% to $3.7M
September 22, 2022
Matinas BioPharma Holdings CEO Jerome Jabbour's 2019 pay rises 6% to $1.3M
October 1, 2020
Matinas BioPharma Holdings CEO Jerome Jabbour's 2018 pay slips 1% to $1.3M
September 24, 2019